Caris Life Sciences annual revenue
2022
2023
2024
2025
Caris Life Sciences Revenue Growth & History (CAI)
Caris Life Sciences reported $812.0M in revenue for fiscal 2025, an increase of 96.97% from the previous fiscal year.
View full Caris Life Sciences company overviewCaris Life Sciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $812.0M | $399.8M | +96.97% |
| 2024 | 2024-12-31 | $412.3M | $106.1M | +34.67% |
| 2023 | 2023-12-31 | $306.1M | $47.6M | +18.43% |
| 2022 | 2022-12-31 | $258.5M | — | — |
Caris Life Sciences quarterly revenue
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $263.7M | $82.3M | +45.38% |
| Q1 2026 | 2026-03-31 | $216.2M | $95.3M | +78.78% |
| Q4 2025 | 2025-12-31 | $292.9M | — | — |
| Q3 2025 | 2025-09-30 | $216.8M | $115.2M | +113.38% |
| Q2 2025 | 2025-06-30 | $181.4M | $81.3M | +81.31% |
| Q1 2025 | 2025-03-31 | $120.9M | — | — |
| Q3 2024 | 2024-09-30 | $101.6M | — | — |
| Q2 2024 | 2024-06-30 | $100.0M | — | — |
Caris Life Sciences revenue growth trends
Caris Life Sciences's latest reported quarter, Q2 2026, generated $263.7M in revenue, an increase of 45.38% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Caris Life Sciences source filings ↗